Kabra Drugs Share Price Today | Stock Price & Kabra Drugs Share Screener

Track the current stock price of Kabra Drugs with an interactive chart. Analyse KABRADG share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Kabra Drugs stock quote in one place.

The quote of ₹18.08 sits between the 52-week low of ₹18.08 and the 52-week high of ₹34.67, and the latest session moved -3.37% from the previous close.

Screen Kabra Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KABRADG shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE323K01017.

Classification

Identifiers and Leadership

Screen KABRADG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹86, up from ₹25 in 2025.

Latest statistics put total assets at ₹86 and shareholder funds at ₹30, with a leverage ratio of 0.02.

Screen Kabra Drugs income statement and profit fundamentals. Analyze KABRADG quarterly results. Kabra Drugs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹132 and net profit was ₹8, equal to earnings per unit of ₹3.20, at an operating margin of 7%.

In that period expenses were ₹123, interest cost ₹0 and tax ₹2. The next period listed, 2026-March, shows revenue of ₹93 and net profit of ₹5.

Screen KABRADG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹10, and net cash flow was an outflow of ₹11.

Over the same period, investing activities used ₹1 and financing activities provided ₹0.

See Kabra Drugs shareholding pattern with promoter, FII, and DII holdings. Check Kabra Drugs promoter holding and ownership changes for KABRADG on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 0.00%, foreign institutions 0.00%, domestic institutions 0.00% and the public 90.92%, spread across 9,185 shareholders.

The shareholder count was 9,185 in 2026-Mar, compared with 9,680 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Kabra Drugs. Kabra Drugs dividend yield can be compared with peers and other stocks in the market.

See which indices include Kabra Drugs stock. Check KABRADG index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Kabra Drugs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Kabra Drugs stock events that may affect KABRADG share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.

It is followed by Quarterly Result Announcement dated August 12, 2026 and Quarterly Result Announcement dated May 29, 2026.

Screen KABRADG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen KABRADG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated October 1, 2026 and September 29, 2026.

Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.